Matches in Wikidata for { <http://www.wikidata.org/entity/Q91756068> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91756068 description "article scientifique publié en 2020" @default.
- Q91756068 description "articolo scientifico (pubblicato il 2020)" @default.
- Q91756068 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q91756068 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q91756068 description "scientific article published on 01 February 2020" @default.
- Q91756068 description "wetenschappelijk artikel" @default.
- Q91756068 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q91756068 name "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 name "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 type Item @default.
- Q91756068 label "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 label "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 prefLabel "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 prefLabel "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU)" @default.
- Q91756068 P1433 Q91756068-183CF3E8-2910-433F-845B-45770BA2E943 @default.
- Q91756068 P1476 Q91756068-A62C6F2A-E9C4-44B9-8443-CB24F9C7C78C @default.
- Q91756068 P2093 Q91756068-63EF6EE1-4636-45DD-841A-D6581734C737 @default.
- Q91756068 P2093 Q91756068-76DDC2FB-1CD9-400F-926B-B4CFB187E27C @default.
- Q91756068 P2093 Q91756068-8EC13C8F-14ED-47FE-8A81-0B6A317450FA @default.
- Q91756068 P2093 Q91756068-A023FAFF-9F7A-4183-A69F-43A8C5662104 @default.
- Q91756068 P2093 Q91756068-A86EDCAB-B705-4A7A-881D-2D787748A7E6 @default.
- Q91756068 P2093 Q91756068-D08F6B4C-BC66-481B-8226-38351BB45F37 @default.
- Q91756068 P2093 Q91756068-D0F2CB5A-1994-41D3-ACE9-A47E1F777ED8 @default.
- Q91756068 P304 Q91756068-32B2876F-DDAF-4795-A8A1-E254B96F89C0 @default.
- Q91756068 P31 Q91756068-FAEC6A37-F3FB-4355-8D8C-0CFB2FB22854 @default.
- Q91756068 P356 Q91756068-C242A91E-2DD6-42FC-8243-45395D4149A1 @default.
- Q91756068 P433 Q91756068-0BFBA27C-0FFB-4295-846E-173A2AC0EF19 @default.
- Q91756068 P478 Q91756068-F312EBAA-43A6-4231-8B67-F7CF8C27996C @default.
- Q91756068 P50 Q91756068-58737433-BEC4-40A3-AC0E-2945D2746628 @default.
- Q91756068 P577 Q91756068-FEC3672F-DF5C-4CBB-B153-82E539581DAB @default.
- Q91756068 P698 Q91756068-733FA69E-2B9D-4F2E-B5F4-2FAB0DF4EA23 @default.
- Q91756068 P921 Q91756068-56F7E4FB-A7E1-429E-9EBC-D9263DF25AB4 @default.
- Q91756068 P921 Q91756068-CCB68A9B-CA23-43A9-81B8-5EF224147326 @default.
- Q91756068 P356 COC.0000000000000644 @default.
- Q91756068 P698 31809326 @default.
- Q91756068 P1433 Q2886177 @default.
- Q91756068 P1476 "Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU) RU261206I" @default.
- Q91756068 P2093 "Asad Javed" @default.
- Q91756068 P2093 "Daniel M Anderson" @default.
- Q91756068 P2093 "Darci J Wall" @default.
- Q91756068 P2093 "Joel M Reid" @default.
- Q91756068 P2093 "Lori A Erickson" @default.
- Q91756068 P2093 "Marc Ernstoff" @default.
- Q91756068 P2093 "Svetomir N Markovic" @default.
- Q91756068 P304 "115-121" @default.
- Q91756068 P31 Q13442814 @default.
- Q91756068 P356 "10.1097/COC.0000000000000644" @default.
- Q91756068 P433 "2" @default.
- Q91756068 P478 "43" @default.
- Q91756068 P50 Q96186734 @default.
- Q91756068 P577 "2020-02-01T00:00:00Z" @default.
- Q91756068 P698 "31809326" @default.
- Q91756068 P921 Q1427096 @default.
- Q91756068 P921 Q413299 @default.